Expression
length substrate into a defined shorter oligonucleotide, and the ratio between the two represents the DNA repair activity. The assays were performed on a robotic platform (Tecan Freedom EVO 200), and the reaction products analyzed by capillary gel electrophoresis, using the ABI3130XL genetic analyzer (Applied Biosystems), and the GeneMapper (Applied Biosystems) and PeakAnalyzer (Robiotec, Rehovot, Israel) software.
Bronchial and nasal sample collection
Bronchial brushings. During diagnostic bronchoscopy procedures three bronchial brushings, designed to gently remove epithelial cells with minimal bleeding, were performed using bronchial brushes (Olympus Medical, Southend, UK). Brushings using disposable cytology brushes (BC-202D-5010 Olympus Japan) were taken from geographically different areas of macroscopically uninvolved main bronchus or lobar bronchi contralateral to the suspected lesion.
Nasal curette samples. Samples of nasal airway epithelium were taken under direct vision from the inferior part of the inferior turbinate of each nostril using nasal curettes (ASI Rhino-Pro; Arlington Scientific Inc.).
RNAseq
Tissue samples from bronchial brushings and nasal curettes were stored in 500µl RNALater overnight at 4 o C, and then at -80 o C for longer-term storage. RNA was extracted using Qiagen
MiRNeasy columns according to manufacturer's protocols. Briefly, bronchial brushes were rinsed in PBS, brushes transferred into 700µl Qiazol and cells lysed by vortexing twice for 30 seconds.
For nasal samples the RNALater containing nasal tissue (500µl) was diluted with 2ml of PBS and spun at 10,000 rpm for 10 min. The cell pellet was lysed by resuspension in 700µl Qiazol. For both types of samples, the Qiazol lysate was applied to a QiaShredder tube (#217004) and spun at 13,000 rpm for 2 mins. The homogenate was kept at room temperature for 5 mins, followed by chloroform extraction using PhaseLock tubes. Nucleic acids in the aqueous phase were precipitated using 1.5 volumes 100% ethanol and DNA was digested using DNAse I. Finally, RNA was isolated from the mixture using RNAeasy mini spin columns. RNA was quantified using a
Qbit measurement and quality assessed using an Agilent Bioanalyzer. For samples with a RIN greater than 7, a total of 500ng of RNA was used for Illumina TruSeq Library generation.
Sequencing was carried on a HiSeq 2500 Illumina sequencers. Sequencing was carried out in two separate multiplexed experiments. Alignment was carried out on the human genome version GRCh37 using the Tophat alignment tool. On average each library contained above 20 Million reads. Count matrices for cases and controls were processed using DESeq2 (5).
Analysis of RNAseq data
As described in the manuscript, analyzing the relationship between the DNA repair score and gene expression, as determined by RNAseq, uncovered that low DNA repair score correlates with upregulation of immune system pathways in lung cancer patients, but not in control subjects. The following sections describe the methods and results of quality control (QC)
procedures, data cleaning and statistical analyses implemented in the main manuscript. The
RNAseq dataset included read counts from 669 nasal and bronchial samples derived from 490 subjects, out of which DNA repair score values were available for 213 subjects. The 669 samples' RNAseq dataset (sequencing batches: 494 samples in experiment 1 and 175 in experiment 2) was used in its entirety for the QC analysis.
Quality control analysis of the RNAseq data
Number of detected genes. Gene transcripts were defined as detected if it had counts of more than 10 reads. Genes with <10 reads were filtered out. Samples with less than 13,000 detected genes were filtered out from the analysis. 97.8% of the samples analyzed in experiment 1 and 98.3% in experiment 2 had >13,000 detected genes.
Experimental batches. We used Principal Component Analysis (PCA) to detect the major sources of variation in the data. As expected, tissue type -nasal (NS) versus bronchial (BR), explains most of the variance followed by sequencing batches (experiment 1 versus experiment 2; Supplementary Fig. 1 ). We did find a few samples that seem to reside in the wrong clusters and removed them from further analysis. Supplementary Fig. 2D ). Hypothesizing that the correlation signal might be distributed over many genes, with each gene having a small effect size, we employed gene set enrichment analysis (GSEA; (6)), testing for pathways enriched with genes that are correlated with the DNA repair OMA score.
Gene set enrichment analysis
The list of genes, ranked by their statistics (as reported in DESeq2) was analyzed by GSEA (GSEA 3.0) in order to identify whether there is an over-representation of genes belonging to specific pathways (annotated by Gene Ontology; GO terms; pathway Gene Ontology downloaded from MSigDB (6),c5.all.v6.1). Supplementary Table 2 lists the thirty most significant pathways that were identified. For each pathway, the enrichment algorithm finds the maximum enrichment score, reflecting the degree to which the genes in the set are over-represented at either the top (positive correlation) or bottom (negative correlation) of the list, and calculates the FDR q-value (the false discovery rate), which is the estimated probability that the enrichment score represents a false positive finding. The pathways were manually curated and divided into 3 groups: Immune system-related pathways, Cell Cycle pathways and Other pathways (see legend to Supplementary Table   3 ). Supplementary Table 3 summarize the pathways that were found to be significantly enriched in nasal samples by GSEA (q-value<0.001, a very strict value as explained in ref (6) Table 3 ).
To visualize the differences in the correlations between DNA repair score and immunesystem pathways, versus DNA repair score and 'Other' pathways, we highlight in differential expression volcano plots two pathways, selected for being relative big and with roughly similar size (~350 genes): the inflammatory response pathway (GO_INFLAMMATORY_RESPONSE, which is an immune system pathway), and the skeletal system development pathway (GO_SKELETAL_SYSTEM_DEVELOPMENT, which belongs to 'Other pathways').
Supplementary Fig. 2 shows Volcano plots, for all the available groups (Cases/Controls)x(Nasal/Bronchial) (in grey dots; Supplementary Fig. 2 A, D, G), highlighting the inflammatory response pathway (in red dots; Supplementary Fig. 2B , E, H) compared to the skeletal system development pathway (in blue dots; Supplementary Fig. 2 C, F, I ). The inflammatory response pathway was found to be enriched in the cases both in nasal and in bronchial tissues (left Volcano lobe, Supplementary Fig. 2 E, H), but not in the controls ( Supplementary Fig. 2B ). The skeletal system development pathway was not enriched in any group/tissue ( Supplementary Fig. 2C, F, I ).
Simulations to test the robustness of the correlation between a low DNA repair OMA score and activity of immune system pathways Extreme OMA score trimming analysis. In this section we repeated the analysis for the nasal tissue samples sequenced in experiment 1, except that we excluded samples with OMA scores at the tails of the OMA distribution, removing 3.5% tail from each side of the OMA scores.
The effect of extreme trimming is presented in Supplementary Fig. 3a , showing the upregulation of the immune pathways also with the trimmed OMA score (compare to Fig. 5 in manuscript) .
Sub-sampling analysis. To get an estimate for the robustness of the results to a more general sampling noise, we conducted 100 iterations of random sub-sampling of subjects and repeated the regression in each iteration. The RNAseq data of the selected random groups of subjects (at 80% of the sample size) were regressed on OMA scores, followed by gene set enrichment analysis, and the number of significant immune system-related pathways (at a q-value<0.001) was determined. Supplementary Fig. 3b shows that 95% of the simulations have more than 117 significant immune system-related pathways (with median value of 137). This analysis is an indication that the results are not sensitive to sampling noise.
Methods and Tools for RNAseq analysis
All Statistical analysis was conducted in R version 3.2.1 (7). All figures were generated with ggplot2 package (8) . Data normalization and regression analysis was done with DESeq2 (5).
GSEA and MSigDB (c5.all.v6.1) were used for GO enrichment (6).
Calculation of 5-year risk of lung cancer
The basis of the calculation was the Liverpool Lung Project (LLP) risk model (9) . coefficient for the OMA score in this model was log(2.5), where 2.5 was the cross-validated odds ratio estimate for the DNA repair score (see Table 3 of the main paper). For a 65-year old male with the above-mentioned profile, the modified model was:
logit (P) = -5.56 + beta-smok -log(2.5) × (OMA -3.553).
In this equation, P is the probability of lung cancer diagnosis within the next 5 years, the value of -5.56 is taken from Table A1 of (9), the value of beta-smok is 0, 0.769, 1.452 or 2.507 respectively for never-smoked, or smoked for 10y, 30y or 50y (taken from Table 2 of (9)), and the value of 3.553 was calculated by us so as to yield an average risk in our control group equal to the average risk in the Liverpool population of males aged 65y in the years 2002-4 (see Table   A1 of (9)).
The model for a 65-year old female was that given in Equation (A1) except that -5.56 was replaced by -5.99 (see Table A1 (9)) and 3.553 was replaced by 3.555 (our calculation).
(e) Equation (1) , as given in Supplementary Table 4) , we used numerical integration over the distribution of OMA scores, assuming the DNA repair score had a normal distribution with mean value of 4.00 (see the control group mean in Table 1 in the main manuscript) and standard deviation 0.98 (the control group's SD).
Supplementary Tables
Supplementary Table 1 Analysis of the robustness of the correlation between low DNA repair OMA score and upregulation of immune-system related pathways. A. Effect of extreme OMA score trimming on the enrichment of immune system pathways with low DNA repair score using gene set enrichment analysis (GSEA). Trimming was performed separately for nasal samples from cases and controls by removing samples with DNA repair OMA values in the 3.5% extreme OMA values from both sides. Genes from the trimmed sub-groups were ranked by the RNAseq2 analysis according to their correlation to the DNA repair score, and analyzed by GSEA to identify pathways (using GO terms) which significantly correlate (negative or positive correlation) with the DNA repair score. The figure represents all Immune system related pathways (depicted by the list of keywords presented in Supplementary Table 3 
